Pooled results from phase 3 clinical trials demonstrate that roxadustat is efficacious and may be comparable to placebo in studies done to date for treating anemia in patients with chronic kidney disease who do not require dialysis.
from Top Health News -- ScienceDaily https://ift.tt/3yqzcxU
Post a Comment